2000
DOI: 10.1016/s0142-9612(00)00064-8
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo evaluation of gelatin–chondroitin sulphate hydrogels for controlled release of antibacterial proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
38
2

Year Published

2005
2005
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(43 citation statements)
references
References 14 publications
3
38
2
Order By: Relevance
“…In particular, their use in pharmaceutics shows promise since recent advancements in biotechnology have led to a great variety of pharmacologically active peptides and proteins that are not adequately released from systems that are not biodegradable. Degradation of the hydrogel microspheres not only allows a tailored release of entrapped molecules, but also circumvents the removal of the empty device from the body [30][31][32] . Although the use of biodegradable hydrogel microspheres related to prolonged and/or controlled drug delivery has been widely investigated, the need for the development of hydrogels using simpler and more feasible methods still exists.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, their use in pharmaceutics shows promise since recent advancements in biotechnology have led to a great variety of pharmacologically active peptides and proteins that are not adequately released from systems that are not biodegradable. Degradation of the hydrogel microspheres not only allows a tailored release of entrapped molecules, but also circumvents the removal of the empty device from the body [30][31][32] . Although the use of biodegradable hydrogel microspheres related to prolonged and/or controlled drug delivery has been widely investigated, the need for the development of hydrogels using simpler and more feasible methods still exists.…”
Section: Discussionmentioning
confidence: 99%
“…The Bio-gel p-60 column was conditioned by sodium phosphate buffer (0.01 M) and NaCl solution (0.15 M, contain 2% BSA) for isolating free iodine from 125 I labeled anti-HSA. In order to immobilize 125 I anti-HSA monoclonal antibody, the 11-mercaptoundecanoic acid/Au surface was immersed in the solution containing coupling agents: 75 mM N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC, E-6383, Sigma) and 15 mM N-hydroxysuccinimide (NHS, H-7377, Sigma) at 4 °C for 30 min (van Delden et al, 1997;Kuijpers et al, 2000). Water-soluble EDC and NHS were used to activate O=C-OH (Kang et al, 1993;Tyan et al, 2002) and then the EDC-NHS solution was replaced by a phosphate buffered saline (PBS, URPBS001, UniRegion Bio-Tech), containing 0.2 μg/mL HSA-antibody at 4 °C for 24 hrs.…”
Section: Immobilization Of Anti-hsamentioning
confidence: 99%
“…The absence of monomers was ensured spectrometrically by ensuring that the water of the washings did not contain any trace of monomers. The SPH was dried in an oven at 60°C for 6 hours [5][6][7][8].…”
Section: Synthesis Of Superporous Hydrogel Compositementioning
confidence: 99%